January 9, 2017 — Arterys has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ...
Monica Saini, M.D., consultant medical director — ABUS at GE Healthcare, discusses the necessity for personalized breast care, and how Automated Breast Ultrasound (ABUS) helps meet the challenges of screening and diagnostic imaging of dense breast tissue.
At the 2016 annual meeting of the Radiological Society of North America (RSNA), Siemens Healthineers presented the Magnetom Sempra, a 1.5T magnetic resonance imaging (MRI) scanner with low operating costs, innovative technologies and a unique, integrated Siemens Healthineers service concept. The Magnetom Sempra is designed to allow radiological practices and groups, as well as small and medium-sized hospitals, to work profitably despite growing cost pressures in the industry. Additionally, the system’s standardized workflows are designed to help institutions achieve consistent, user-independent quality.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
January 9, 2017 — The American College of Radiology has updated its ACR Appropriateness Criteria to cover 227 topics ...
Fujifilm Medical Systems U.S.A. Inc. presented the next generation of its X-ray image processing technology, Dynamic Visualization II, at the 2016 annual meeting of the Radiological Society of North America (RSNA), Nov. 27– Dec. 1 in Chicago.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
EIZO is proud to be entering into its 45th year of expertise, meeting hospital demands worldwide in over 80 countries. This year we are excited to unveil a few never-seen before, brand new products, including the RadiForce RX660.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Conserus Workflow Intelligence helps you improve quality and efficiency, all within your regular PACS workflow. To learn more about how it can help you improve communication and turnaround times in your health system, watch this brief video.
Nuance Communications Inc. announced in November that it enhanced its PowerShare Network capabilities in collaboration with Coordinated Care of Oklahoma (CCO) to make image awareness in health information exchanges (HIEs) now a reality. CCO is a leading health information network of hospitals, health systems and physicians in Oklahoma.
Mirada Medical showcased its latest XD:PACS (picture archiving and communication system) range of molecular imaging products at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 1 in Chicago.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality images. Optimal dosing for individual patients can be difficult to determine. That’s where 3-D-printed organ models of varying size and shape could be of great use.
Image Information Systems released version 3.0 of its iQ-VIEW radiology reading station in November and displayed it at the 2016 annual meeting of the Radiological Society of North America (RSNA) in Chicago.
SyntheticMR AB introduced REMyDI for automatic quantification of myelin volume in the brain at the 2016 annual meeting of the Radiological Society of North America (RSNA) in November. Easy quantification of myelin allows clinicians to follow myelination in the developing brain and monitor myelin degeneration in patients with demyelinating and neurodegenerative disorders. REMyDI is a feature of the SyMRI post-processing software from SyntheticMR.
Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...
New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of prostate cancer, even in areas where detection has previously been difficult. Published in the December issue of The Journal of Nuclear Medicine, the Phase 1 dose-escalation study of Zr-89-desferrioxamine-IAB2M (Zr-89-Df-IAB2M), an anti-PSMA (prostate-specific membrane antigen) minibody, in patients with metastatic prostate cancer shows its effectiveness in targeting both bone and soft tissue lesions.
Toshiba Medical announced in November that its Vantage Titan 1.5T/cS Edition magnetic resonance imaging (MRI) system with M-Power V3.6 software received U.S. Food and Drug Administration (FDA) clearance at the 2016 annual meeting of the Radiological Society of North America (RSNA). The new system retains all the patient-friendly features of the Vantage Titan 1.5T MR with added technology to simplify complex cardiac exams.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
January 5, 2017 — Varian Medical Systems recently announced the launch of a new website for the exchange of clinical ...
Intelerad Medical Systems recently announced the launch of RendezVous, an integrated solution that combines Intelerad’s Teaching Files module with advanced study tagging functionality.
Too little sleep takes a toll on your heart, according to a new study presented at the 2016 annual meeting of the Radiological Society of North America (RSNA), Nov. 27-Dec. 1 in Chicago.
Join Chris Toth, president, Oncology Systems Americas, for a look at Varian’s new product introductions and major ...
January 5, 2017 — Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal Accreditation ...
iCAD Inc. announced that researchers presented updated data on the use of intraoperative radiation therapy (IORT) with the Xoft Axxent Electronic Brachytherapy (eBx) System during the San Antonio Breast Cancer Symposium (SABCS), Dec. 6-10 in San Antonio, Texas. The data include results from a subset of patients who received IORT with the Xoft System as a boost prior to administration of whole breast radiation therapy (WBRT) in patients with early-stage breast cancer.